WO2010042742A3 - Agents thérapeutiques chimères, compositions et procédés permettant de les utiliser - Google Patents
Agents thérapeutiques chimères, compositions et procédés permettant de les utiliser Download PDFInfo
- Publication number
- WO2010042742A3 WO2010042742A3 PCT/US2009/060038 US2009060038W WO2010042742A3 WO 2010042742 A3 WO2010042742 A3 WO 2010042742A3 US 2009060038 W US2009060038 W US 2009060038W WO 2010042742 A3 WO2010042742 A3 WO 2010042742A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- same
- nucleic acid
- core protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6919—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a ribbon or a tubule cochleate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3513—Protein; Peptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des agents thérapeutiques comprenant une protéine centrale virale modifiée et un acide nucléique lié à cette protéine centrale virale modifiée. Dans certains modes de réalisation, l'acide nucléique peut être sensiblement homologue d'une cible d'un gène spécifique. Dans certains modes de réalisation, l'acide nucléique lié à la protéine centrale virale modifiée est essentiellement non-immunogène.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10383508P | 2008-10-08 | 2008-10-08 | |
US61/103,835 | 2008-10-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010042742A2 WO2010042742A2 (fr) | 2010-04-15 |
WO2010042742A3 true WO2010042742A3 (fr) | 2010-10-14 |
Family
ID=42101212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/060038 WO2010042742A2 (fr) | 2008-10-08 | 2009-10-08 | Agents thérapeutiques chimères, compositions et procédés permettant de les utiliser |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010042742A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2056845B1 (fr) | 2006-08-08 | 2017-10-11 | Rheinische Friedrich-Wilhelms-Universität Bonn | Structure et utilisation d'oligonucléotides 5'-phosphate |
JP5689413B2 (ja) | 2008-05-21 | 2015-03-25 | ライニッシュ フリードリッヒ−ウィルヘルムズ−ユニバーシタット ボン | 平滑末端を有する5’三リン酸オリゴヌクレオチドおよびその使用 |
EP2508530A1 (fr) | 2011-03-28 | 2012-10-10 | Rheinische Friedrich-Wilhelms-Universität Bonn | Purification d'oligonucléotides triphosphorylés au moyen d'étiquettes de capture |
EP2712870A1 (fr) | 2012-09-27 | 2014-04-02 | Rheinische Friedrich-Wilhelms-Universität Bonn | Nouveaux ligands de RIG-I et procédés pour les produire |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0442394B1 (fr) * | 1990-02-16 | 2000-08-16 | United Biomedical, Inc. | Peptides synthétiques spécifiques pour la détection d'anticorps contre HVC et diagnostic des infections par HVC |
US6235284B1 (en) * | 1992-05-06 | 2001-05-22 | Bio Merieux | Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter |
WO2004042001A2 (fr) * | 2002-05-17 | 2004-05-21 | Emory University | Particules pseudovirales, procede de fabrication et compositions immunogeniques |
-
2009
- 2009-10-08 WO PCT/US2009/060038 patent/WO2010042742A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0442394B1 (fr) * | 1990-02-16 | 2000-08-16 | United Biomedical, Inc. | Peptides synthétiques spécifiques pour la détection d'anticorps contre HVC et diagnostic des infections par HVC |
US6235284B1 (en) * | 1992-05-06 | 2001-05-22 | Bio Merieux | Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter |
WO2004042001A2 (fr) * | 2002-05-17 | 2004-05-21 | Emory University | Particules pseudovirales, procede de fabrication et compositions immunogeniques |
Non-Patent Citations (1)
Title |
---|
SOO HO CHOI ET AL.: "Hepatitis C Virus Core Protein Is Efficiently Released into the Culture Medium in Insect Cells", JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 37, no. 6, November 2004 (2004-11-01), pages 735 - 740 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010042742A2 (fr) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010042755A3 (fr) | Agents thérapeutiques chimères, compositions et méthodes d'utilisation | |
WO2010042749A3 (fr) | Agents thérapeutiques chimères, compositions et procédés permettant de les utiliser | |
WO2010042751A3 (fr) | Agents thérapeutiques chimères, compositions et procédés permettant de les utiliser | |
WO2012045082A3 (fr) | Synthèse d'acides nucléiques et méthodes d'utilisation associées | |
WO2009149956A3 (fr) | Protéine de fusion et son utilisation | |
WO2009042186A3 (fr) | Edition génomique dans un dard-perche à l'aide de nucléases à doigt de zinc | |
WO2009149202A3 (fr) | Compositions et procédés comprenant des variants de cellulase avec une affinité réduite pour les matières non cellulosiques | |
GB2470672B (en) | Methods of RNA amplification in the presence of DNA | |
WO2010062480A3 (fr) | Procédés et compositions pour la production d'alcools gras | |
WO2009120374A3 (fr) | Procédés et compositions pour la préparation d’échantillon d’acide nucléique | |
WO2011005799A3 (fr) | Molécules d'arn autorépliquantes et leurs utilisations | |
WO2008104890A3 (fr) | Compositions et procédés de production d'apolipoprotéine | |
WO2009126250A3 (fr) | Reprogrammation d’une cellule par induction d’un gène pluripotent par interférence arn | |
WO2012135805A3 (fr) | Administration et formulation d'acides nucléiques génétiquement modifiés | |
WO2011072246A3 (fr) | Modification de l'adn induite par l'effecteur tal | |
WO2009099641A3 (fr) | Compositions protéiniques stabilisées | |
WO2010120874A3 (fr) | Agents thérapeutiques chimériques, compositions, et leurs procédés d'utilisation | |
WO2008067423A3 (fr) | Procédé d'amélioration de l'introduction d'adn dans des cellules bactériennes | |
WO2009137778A3 (fr) | Procédés et compositions pour l'obtention de l'espèce clostridia par génie génétique | |
WO2009099877A3 (fr) | Vecteurs de closterovirus et procédés | |
WO2010039802A3 (fr) | Procédés et compositions pour isoler un acide nucléique | |
WO2011153276A3 (fr) | Enzymes cellobiohydrolases chimères fonctionnelles et stables de classe i | |
HK1136849A1 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells rna | |
WO2008079895A3 (fr) | Méthodes permettant d'obtenir une compétence génétique chez de cellules de type bacillus | |
HK1142928A1 (zh) | 在經修飾的隨機寡核苷酸的存在下的核酸擴增 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09819898 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 01-08-2011) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09819898 Country of ref document: EP Kind code of ref document: A2 |